Cytta (CYCA) 10-Q 14 Feb 25 2025 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Dec. 31, 2024	Feb. 14, 2025
Cover [Abstract]
Entity Registrant Name	CYTTA CORP.
Entity Central Index Key	0001383088
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Dec. 31, 2024
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2025
Entity Common Stock Shares Outstanding		470,237,826
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	333-257458
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	98-0505761
Entity Address Address Line 1	5450 W Sahara Ave Suite 300A
Entity Address City Or Town	Las Vegas
Entity Address State Or Province	NV
Entity Address Postal Zip Code	89146
City Area Code	702
Local Phone Number	900-7022
Security 12g Title	Common Stock, $0.001 par value
Entity Interactive Data Current	Yes

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Dec. 31, 2024	Sep. 30, 2024
Current Assets
Cash	$ 1,008,186	$ 1,439,835
Accounts receivable	230,835	0
Prepaid expenses - related party	421,334	421,334
Prepaid expenses - other	53,171	122,712
Total Current Assets	1,713,526	1,983,881
Prepaid expenses - related party, non-current	35,109	140,443
Property and equipment, net	40,573	50,867
TOTAL ASSETS	1,789,208	2,175,191
Current Liabilities
Accounts payable and accrued expenses	655,324	527,678
Related party liabilities	423,997	443,093
Deferred revenue	195,524	2,914
Convertible notes payable	1,438,950	1,438,950
Total Current Liabilities and Total Liabilities	2,713,795	2,412,635
COMMITMENTS AND CONTINGENCIES	0	0
Stockholders' Deficit
Common stock par value $0.001; (600,000,000 shares authorized and 469,877,826 shares issued and outstanding)	469,879	469,879
Additional paid in capital	36,159,919	36,159,919
Accumulated Deficit	(37,555,035)	(36,867,892)
Total Stockholders' Deficit	(924,587)	(237,444)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	1,789,208	2,175,191
Series F Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, value	0	0
Series C Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, value	600	600
Series D Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, value	50	50
Series E Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, value	$ 0	$ 0

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2024	Sep. 30, 2024
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	100,000,000	100,000,000
Common stock share, par value	$ 0.001	$ 0.001
Common stock share, authorized	600,000,000	600,000,000
Common stock share, issued	469,877,826	469,877,826
Common stock share, outstanding	469,877,826	469,877,826
Series F Preferred Stock [Member]
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	59,270,000	59,270,000
Preferred stock share, issued	0	0
Preferred stock share, outstanding	0	0
Series C Preferred Stock [Member]
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	12,000,000	12,000,000
Preferred stock share, issued	600,000	600,000
Preferred stock share, outstanding	600,000	600,000
Series D Preferred Stock [Member]
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	10,000,000	10,000,000
Preferred stock share, issued	50,000	50,000
Preferred stock share, outstanding	50,000	50,000
Series E Preferred Stock [Member]
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	13,650,000	13,650,000
Preferred stock share, issued	0	0
Preferred stock share, outstanding	0	0

STATEMENTS OF OPERATIONS (Unaud

STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
STATEMENTS OF OPERATIONS (Unaudited)
Revenues	$ 38,225	$ 2,411
Cost of revenues	18,459	0
Gross Profit	19,766	2,411
Operating Expenses:
General and administrative - related party	221,738	213,208
General and administrative - other	420,469	777,244
Total operating expenses	642,207	990,452
Loss from Operations	(622,441)	(988,041)
Other expenses (income)
Interest expense	64,702	71,287
Interest income	0	(200)
Total Other Expenses (Income)	(64,702)	(71,087)
Loss before income taxes	(687,143)	(1,059,128)
Provision for income taxes	0	0
Net loss	$ (687,143)	$ (1,059,128)
Loss per share, basic and diluted	$ 0	$ 0
Weighted average shares outstanding Basic and diluted	469,877,826	428,575,956

STATEMENT OF CHANGES IN STOCKHO

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)	Total	Preferred Stock Series C [Member]	Preferred Stock Series D [Member]	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)
Balance, shares at Sep. 30, 2023		600,000	50,000	426,831,170
Balance, amount at Sep. 30, 2023	$ (260,359)	$ 600	$ 50	$ 426,832	$ 31,915,639	$ (32,603,480)
Common stock and warrants issued for services, shares				6,000,000
Common stock and warrants issued for services, amount	169,200	0	0	$ 6,000	163,200	0
Common stock issued for accounts payable and accrued liabilities, shares				1,887,750
Common stock issued for accounts payable and accrued liabilities, amount	50,781	0	0	$ 1,888	48,893	0
Net loss for the three months ended December 31, 2023	(1,059,128)	$ 0	$ 0	$ 0	0	(1,059,128)
Balance, shares at Dec. 31, 2023		600,000	50,000	434,718,920
Balance, amount at Dec. 31, 2023	(1,099,506)	$ 600	$ 50	$ 434,720	32,127,732	(33,662,608)
Balance, shares at Sep. 30, 2024		600,000	50,000	469,877,826
Balance, amount at Sep. 30, 2024	(237,444)	$ 600	$ 50	$ 469,879	36,159,919	(36,867,892)
Net loss for the three months ended December 31, 2023	(687,143)	$ 0	$ 0	$ 0	0	(687,143)
Balance, shares at Dec. 31, 2024		600,000	50,000	469,877,826
Balance, amount at Dec. 31, 2024	$ (924,587)	$ 600	$ 50	$ 469,879	$ 36,159,919	$ (37,555,035)

STATEMENTS OF CASH FLOWS (Unaud

STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (687,143)	$ (1,059,128)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expenses for services - related party	123,783	123,208
Stock-based compensation expenses for services - other	135,234	476,308
Amortization of note discounts	0	15,353
(Gain) loss on debt extinguishment	0	(3,955)
Depreciation expense	10,294	10,576
Changes in Operating Assets and Liabilities:
Accounts receivable	(230,835)	0
Prepaid expenses - other	(11,747)	63,285
Accounts payable and accrued liabilities	73,701	31,252
Accounts payable - related party	(37,546)	13,040
Deferred revenue	192,610	(2,411)
Net cash used in operating activities	(431,649)	(324,562)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of short-term convertible notes payable	0	40,000
Net cash provided by financing activities	0	40,000
NET CHANGE IN CASH	(431,649)	(284,562)
CASH AT BEGINNING OF YEAR	1,439,835	674,824
CASH AT END OF YEAR	1,008,186	390,262
SUPPLEMENTAL CASH FLOW DISCLOSURES
Cash paid for interest	0	0
Cash paid for income taxes	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES
Common stock issued for services	0	169,200
Common stock issued for accounts payable and accrued liabilities	$ 0	$ 50,781

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS	3 Months Ended
	Dec. 31, 2024
ORGANIZATION AND DESCRIPTION OF BUSINESS
ORGANIZATION AND DESCRIPTION OF BUSINESS	NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS Cytta Corp., (“Cytta” or the “Company”) was incorporated on May 30, 2006, under the laws of the State of Nevada. It is located in Las Vegas, Nevada. Cytta is in the business of imagineering, developing and securing disruptive technologies. The Company's proprietary CyttaCOMMS incident management software system offers real-time integration of video and audio streams, enabling improved collaboration and providing ongoing, relevant, actionable intelligence. Their innovative new product, CyttaCARES, is a game-changer in ensuring the safety and well-being of individuals in educational institutions and beyond. Cytta's CyttaCOMP ISTAR (Intelligence, Surveillance, Target Acquisition and Reconnaissance) technology delivers real-time compression of video streams with ultra-low latency, even in low bandwidth environments in conjunction with their compression Licensee Reticulate Micro, Inc. Cytta’s proprietary SUPR Intelligence, Surveillance and Reconnaissance (ISR) technology designated CyttaCOMP, is now licensed to Reticulate Micro, Inc. CyttaCOMP, is at the core of our products and is the most potent software compression codec commercially available. CyttaCOMP is explicitly designed for realtime streaming of HD, 4K, and higher resolution video while requiring only limited bandwidth and minimal computational resources. Cytta’s CyttaCOMMS (formerly IGAN Incident Command System (ICS) system) seamlessly streams and integrates all available video and audio sources during emergencies, enabling sharing of multiple video and audio inputs. The CyttaCOMMS product was introduced into the market in the last quarter of 2024. The CyttaCOMMS online software platform is fully SaaS based with no hardware components. The CyttaCOMMS introduces immediate real-time video and audio situational awareness, which is valuable for police, firefighters, first responders, emergency medical workers, industry, environmental and emergencies, security, military, and all their command centers in any emergency. The proprietary IGAN software technology powers, Cytta’s SaaS Based COMMS system creates an integrated communications platform which seamlessly streams all available video and audio sources in all critical situations, for first responders enabling real time event and interactive mapping information. Also based upon the IGAN technology, Cytta’s CyttaCARES (Crisis Alert and Response Emergency System) system is an innovative SAAS solution designed to enhance safety and security in educational institutions especially during emergency situations. This comprehensive system provides real-time alerts, rapid two-way secure video communication, and efficient response coordination with live location tracking to emergency response teams. We have created advanced video compression (SUPR), video/audio streaming and collaboration software (CyttaCOMMS), and school and institution safety and security software systems (CyttaCARES) that solve real world streaming, safety and security problems for multiple institutions and organizations. We believe our products will enable and empower the world to consume higher quality video anywhere, anytime while providing unparallelled safety and security

GOING CONCERN

GOING CONCERN	3 Months Ended
	Dec. 31, 2024
GOING CONCERN
GOING CONCERN	NOTE 2 - GOING CONCERN The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of December 31, 2024, the Company had an accumulated deficit of $37,555,035, a working capital deficit of $1,000,269 and has also generated losses since inception. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties. The Company intends to fund operations through equity and/or debt financing arrangements, which may not be sufficient to fund its capital expenditures, working capital and other cash requirements for the foreseeable future.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Dec. 31, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of December 31, 2024, and the results of operations and cash flows for the periods presented. The results of operations for the three months ended December 31, 2024, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited financial statements should be read in conjunction with the audited financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K filed on January 14, 2025, for the year ended September 30, 2024. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates. Reclassifications Certain prior period amounts have been reclassified to conform with the current period presentation. Cash and Cash Equivalents The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits of $250,000 per financial institution. The amount in excess of the FDIC insurance as of December 31, 2024, was approximately $750,000. The Company has no cash equivalents at December 31, 2024, and September 30, 2024. Prepaid expenses The Company considers expenses or services paid for prior to the period the expense is incurred to be recorded as a prepaid expense. Included in this account is the value of common stock, options and warrants issued to consultants. Such issuances are pursuant to consulting agreements that can have a one-to-two-year term. The Company amortized the value of the stock issued over the term of the agreement. The activity for the three months ended December 31, 2024, and 2023 is summarized as: December 31, 2024 2023 Balance beginning of period $ 684,489 $ 1,548,752 Amortization of stock-based compensation (186,621 ) (389,260 ) Other prepaid expense activity 11,746 (63,285 ) Sub-total 509,614 1,096,207 Less non-current portion (all related party) 35,109 456,443 Prepaid expenses, current portion 474,505 639,764 Less prepaid expenses – related party, current portion 421,334 421,334 Prepaid expenses – other, current portion $ 53,171 $ 218,430 Property and equipment Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets. The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows: Vehicles and equipment 5 years Software 3 years Convertible Instruments The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. In August 2020, the FASB issued Accounting Standards Update 2020-06 (ASU 2020-06). ASU 2020-06 eliminates the beneficial conversion feature and cash conversion models in Accounting Standards Codification 470-20 that require separate accounting for embedded conversion features in convertible instruments. The new guidance also eliminates some of the conditions that must be met for equity classification under ASC 815-40-25. The standard is effective for smaller reporting companies for annual periods beginning after December 15, 2023. Early adoption is permitted. The Company chose to early adopt this standard. As a result, financial results contained herein are reported in accordance with this standard as applicable. The convertible debt issued by the Company referred to in Note 7, did not require separate accounting for the conversion feature as it was not considered to be a derivative. The Company issued warrants in connection with the debt financing and in accordance with ASC 470-20-25-2 the proceeds from the sale of the debt instruments have been allocated to the debt and warrants based on the relative fair value of the two components. The amount allocated to the warrants has been recorded as a debt discount to be amortized of the life of the note. Fair value of financial instruments The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: ● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities. ● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, accounts payable and accrued expenses, related party liabilities, and deferred revenue, approximate their fair values because of the short maturity of these instruments. Revenue recognition Our revenues are primarily generated from fees charged in connection with the implementation of our software platform (including the sale of SaaS products and services, maintenance associated with the sale of on premise software licenses). Our revenue recognition policy follows the guidance from Accounting Standards Codification (“ASC”) 606, “Revenue Recognition,” and Accounting Standards Update No. 2014-09 – Revenue from Contracts with Customers (Topic 606) which provide guidance on the recognition, presentation, and disclosure of revenue in financial statements. We determine revenue recognition through the following steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract and (v) recognition of revenue when a performance obligation is satisfied. Revenue from fees charged in connection with the implementation of our software platform is recognized ratably over the term specified with the customers, which is primarily one year. The transaction price is the amount of consideration to which the Company expects to be entitled to receive in exchange for providing access to its platform. Maintenance and support services generally call for the Company to provide software updates and technical support to customers and is recognized ratably over the term of the contract as this is the period the services are delivered. The Company does not view the provision of initial setup services as a discrete earnings event that is distinct. Our standard payment terms are generally no more than 60 days. SaaS and maintenance services are typically invoiced annually in advance. Amounts billed or collected in excess of revenue recognized are included as deferred revenue. For the three months ended December 31, 2024, and 2023, the Company derives all of its revenues from the 1-year license software/hosting package of CyttaComms IGAN v3.0 unlimited channels/users and streams. Accounts receivable The Company records accounts receivable at the time services are invoiced when the access to our platform is delivered or provided to the customers. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience. Stock-based compensation The Company accounts for its stock based compensation under the recognition and measurement principles of the fair value recognition provisions of Statement of Financial Accounting Standards No. 123 (revised 2004) “Share-Based Payment” (ASC 718) using the modified prospective method for transactions in which the Company obtains employee services in share-based payment transactions and the Financial Accounting Standards Board Emerging Issues Task Force Issue No. 96-18 “Accounting For Equity Instruments That Are Issued To Other Than Employees For Acquiring, Or In Conjunction With Selling Goods Or Services” (“EITF No. 96-18”) for share-based payment transactions with parties other than employees provided in (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the grant date. Income taxes The Company accounts for income taxes under Statement of Financial Accounting Standards No. 109 “Accounting for Income Taxes” (“SFAS No. 109”) (ASC 740). Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date. Cash flows reporting The Company follows the provisions of ASC 230 for cash flows reporting and accordingly classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230 to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. Reporting segments ASC 280 establishes standards for the way that public enterprises report information about operating segments in annual financial statements and requires reporting of selected information about operating segments in interim financial statements regarding products and services, geographic areas and major customers. ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company’s financial statements as substantially all of the Company’s operations are conducted in one industry segment. Concentrations of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited. Earnings (Loss) Per Share of Common Stock The Company has adopted ASC 260-10-20, “Earnings per Share,” (“EPS”) which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Recent Accounting Pronouncements There have been no recent accounting pronouncements or changes in accounting pronouncements during the three months ended December 31, 2024, that are of significance or potential significance to the Company.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	3 Months Ended
	Dec. 31, 2024
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT	NOTE 4 - PROPERTY AND EQUIPMENT The following table represents the Company’s property and equipment as of December 31, 2024, and September 30, 2024: December 31, 2024 September 30, 2024 Property and equipment $ 245,606 $ 245,606 Accumulated depreciation (205,033 ) (194,739 ) Property and equipment, net $ 40,573 $ 50,867 Depreciation expense was $10,294 and $10,576 for the three months ended December 31, 2024, and 2023, respectively.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Dec. 31, 2024
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 5 - RELATED PARTY TRANSACTIONS Related Party agreements and fees For the three months ended December 31, 2024, and 2023, the Company recorded expenses to related parties in the following amounts: Three months ended December 31, 2024 2023 Management fees, Chief Executive Officer (CEO) $ 45,000 $ 45,000 President and Chief Operating Officer (COO) 45,000 45,000 Stock-based compensation expense, officers 123,783 123,208 Office rent and expenses 7,955 - Total $ 221,738 $ 213,208 Effective January 1, 2023, the monthly fee for the CEO was $15,000. Effective February 1, 2023, the Company entered a Consulting Executive Officer Agreement with a three- year term to an entity (SGG World LLC or "SGG") to provide the services of a Chief Operating Officer (the “COO”) of the Company. On October 1, 2023, the BOD also appointed the COO as the President. Pursuant to the agreement, the Company agreed to a monthly fee of $10,000, and the issuance of 250,000 common shares per month, to be issued semi-annually. The monthly fee was increased to $15,000 per month effective September 1, 2023. For the three months ended December 31, 2024, and 2023, the Company recorded expenses of $18,450 and $17,875, respectively, related to the 250,000 common shares per month, calculated based on the closing market price of the common stock on the last day of each month. The Company granted an option to SGG purchase 10,000,000 shares of the Company’s common stock at $0.02 per share with an expiry date of July 1, 2025 (the "CYCA Option”). The CYCA option vests at the rate of 25% beginning on the first six-month anniversary of the agreement, as well as a warrant to purchase 250,000 shares of the Reticulate Micro common stock the Company owns (the “RM Warrant”). The RM Warrant has an exercise price of $1.00 per share and an expiry date of July 1, 2025. The Company valued the CYCA Option at $639,543 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $53,295 is included in stock-based compensation expense-related party for the three months ended December 31, 2024, and 2023, respectively. The Company valued the RM Warrant at $624,458 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $52,038 is included in stock-based compensation expense-related party for the three months ended December 31, 2024, and 2023, respectively. Beginning in April 2024, the Company agreed to rent office space for the COO at $2,575 per month plus incidental expenses, on a month to month basis, accordingly, $7,955 is included in related party expenses for the three months ended December 31, 2024. Related party liabilities As of December 31, 2024, and September 30, 2024, the Company owes $423,997 and $443,093, respectively, to related parties as follows: December 31, 2024 September 30, 2024 Management fees, Chief Executive Officer (CEO) $ 110,000 $ 110,000 Bonus, CEO 48,040 68,040 Stock to be issued President and COO 227,085 208,635 Accounts payable, President and COO 8,872 26,418 Fees, bonus, and accounts payable, former CTO 30,000 30,000 Total $ 423,997 $ 443,093

NOTE PAYABLE

NOTE PAYABLE	3 Months Ended
	Dec. 31, 2024
NOTE PAYABLE
NOTES PAYABLE	NOTE 6 - NOTE PAYABLE On January 10, 2023, the Company entered into an 8%, $40,000 face value promissory note with a third-party lender with a maturity date the earlier of the Company raising $1,000,000 in debt or equity, or January 10, 2024. The lender may extend the maturity date for an additional one year at their option by providing 30 days written notice to the Company before the maturity date. Effective January 10, 2024, the lender amended and restated the note with a principal balance of $43,200, that matures on July 10, 2024, with an interest rate of 8% and pledged 45,000 shares of RM stock as collateral for the note. On August 12, 2024, the Company has agreed to transfer 45,000 shares of RM stock to RM (the lender) for satisfaction of the note and accrued and unpaid interest.

CONVERTIBLE NOTES PAYABLE

CONVERTIBLE NOTES PAYABLE	3 Months Ended
	Dec. 31, 2024
CONVERTIBLE NOTES PAYABLE
CONVERTIBLE NOTES PAYABLE	NOTE 7 - CONVERTIBLE NOTES PAYABLE During the quarter ended March 31, 2023, (the “March 2023 Notes”) the Company issued five (5) convertible promissory notes, in the aggregated principal amount of $160,000, to investors. The notes bear an interest rate of 18% per annum. Principal amount of $100,000 matured on July 1, 2024, and have been extended to July 1, 2025, while principal amount of $60,000 matured on various dates of February 2024 and have all been extended to May 31, 2025. Interest payments are due quarterly. The Holders shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of Reticulate Micro (the “RM Stock”) owned by the Company. The notes are convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note. In conjunction with one note of $50,000, the Company issued a warrant to purchase 2,000,000 shares of common stock at an exercise price of $0.025 with an expiration date of July 1, 2025, and a warrant to purchase 100,000 shares of RM Stock at $1.00 per share with an expiry date of July 1, 2025. The warrants issued to purchase the Company’s common stock, and the RM Stock resulted in a debt discount of $43,416, with the offset to additional paid in capital. For the three months ended December 31, 2023, amortization of the debt discounts of $7,662 was charged to interest expense. In conjunction with one note of $50,000, the Company issued a warrant to purchase 2,000,000 shares of common stock at an exercise price of $0.025 with an expiration date of July 1, 2025, and a warrant to purchase 100,000 shares of RM Stock at $1.00 per share with an expiry date of July 1, 2025. The warrants issued to purchase the Company’s common stock, and the RM Stock resulted in a debt discount of $43,585, with the offset to additional paid in capital. For the three months ended December 31, 2023, amortization of the debt discounts of $7,692, was charged to interest expense. Both debt discounts were fully amortized as of September 30, 2024. As of December 31, 2024, and September 30, 2024, the outstanding principal balance of the March 2023 Notes was $160,000. During the quarter ended December 31, 2023, (the “December 2023 Notes”) the Company issued a convertible promissory note of $40,000, to an investor. The note bears an interest rate of 18% per annum and matured during the quarter ended December 31, 2024, and has been extended to May 31, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note. As of December 31, 2024, and September 30, 2024, there is a balance due of $40,000 on the December 2023 Notes. During the quarter ended March 31, 2024, (the “March 2024 Notes”) the Company issued nine (9) convertible promissory notes in the aggregate of $517,500, to investors. The notes bear an interest rate of 18% per annum and mature during the quarter ended March 31, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $2.00 per share, excluding a note of $250,000 which has a conversion price of $1.00 of RM stock for principal and $2.50 of RM stock for interest. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $2.00 per share to equal the outstanding principal and interest due upon any defaults of the note. During the year ended September 30, 2024, the lenders of $167,500 of the March 2024 Notes agreed to settle the notes by the issuance of 83,750 shares of RM stock for the principal amount. As of December 31, 2024, and September 30, 2024, there is a balance of $350,000 due on the March 2024 Notes. Among the total $350,000 balance, principal of $250,000 matured on January 22, 2025, which, together with $45,000 of accrued and unpaid interest, was fully converted into 295,000 shares of RM stock owned by the Company in January 2025 (see Note 13), and remaining principal of $100,000 matures in various dates of March 2025. During the quarter ended June 30, 2024, (the “June 2024 Notes”) the Company issued thirty eight (38) convertible promissory notes in the aggregate of $1,910,950 to investors. The notes bear an interest rate of 18% per annum and mature during the quarter ending June 30, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $2.00 per share, excluding $85,000 of June 2024 Notes where the conversion price is $1.00 for the RM stock and $15,000 of June 2024 Notes where the conversion price is $0.025 for the Company’s common stock. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $2.00 per share to equal the outstanding principal and interest due upon any defaults of the note. During the year ended September 30, 2024, the lenders of $1,147,000 of the June 2024 Notes agreed to settle the notes by the issuance of 573,500 shares of RM stock for the principal amount. As of December 31, 2024, and September 30, 2024, there is a balance of $763,950 due on the June 2024 Notes. During the quarter ended September 30, 2024, (the “September 2024 Notes”) the Company issued two (2) convertible promissory notes in the aggregate of $125,000 to investors. The notes bear an interest rate of 18% per annum and mature during the quarter ended September 30, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $2.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $2.00 per share to equal the outstanding principal and interest due upon any defaults of the note. As of December 31, 2024, and September 30, 2024, there is a balance of $125,000 due on the September 2024 Notes. The activity for the three months ended December 31, 2024, and 2023, is summarized as follows: December 31, 2024 December 31, 2023 Beginning balance, face value $ 1,438,950 $ 1,215,000 Convertible notes issued - 40,000 Convertible note discount - (32,859 ) Ending balance $ 1,438,950 $ 1,222,141 The Company has the following convertible notes payable outstanding as of December 31, 2024, and September 30, 2024: December 31, 2024 September 30, 2024 March 2023 Convertible notes payable, interest at 18%, $60,000 matures May 31, 2025, and $100,000 matures July 1, 2025 $ 160,000 $ 160,000 December 2023 Convertible note payable, interest at 18%, matures May 31, 2025 40,000 40,000 March 2024 Convertible notes payable, interest at 18%, $250,000 matured January 22, 2025, and $100,000 matures various dates of March 2025 350,000 350,000 June 2024 Convertible notes payable, interest at 18%, matures during quarter ending June 30, 2025 763,950 763,950 September 2024 Convertible notes payable, interest at 18%, matures during quarter ending September 30, 2025 125,000 125,000 Convertible notes payable, balance $ 1,438,950 $ 1,438,950

CAPITAL STOCK

CAPITAL STOCK	3 Months Ended
	Dec. 31, 2024
CAPITAL STOCK
CAPITAL STOCK	NOTE 8 - CAPITAL STOCK Common Stock The Company has authorized 600,000,000 common shares, par value $0.001. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. As of December 31, 2024, and September 30, 2024, there were 469,877,826, respectively, common shares issued and outstanding. There were no shares of common stock issued during the three months ended December 31, 2024. During the three months ended December 31, 2023, the following shares of common stock were issued: ● 6,000,000 shares of common issued for services. The Company valued the shares at $169,200 based on the price of the common stock on the date the Company agreed to issue the shares. ● 1,887,750 shares issued for payment of $46,826 of accounts payable and accrued interest. The value of the shares issued was $50,781 based upon the share price of the Company’s common stock on the date the Company agreed to issue the common stock. The Company included $3,955 in loss on debt extinguishment for the three months ended December 31, 2023. Preferred Stock The Company has 100,000,000 shares authorized as preferred stock, par value $0.001 (the “Preferred Stock”), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time. Series C Preferred Stock Under the terms of the Certificate of Designation of Series C Preferred Stock, 12,000,000 shares of the Company’s preferred shares are designated as Series C Preferred Stock. Each share of Series C Preferred Stock is convertible into one hundred shares Common Stock and each share of Series C Preferred Stock is entitled to one hundred votes. As of December 31, 2024, and September 30, 2024, there were 600,000 shares of Series C Preferred Stock issued and outstanding. Series D Preferred Stock On September 30, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series D Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series D Preferred Stock, 10,000,000 shares of the Company’s preferred shares are designated as Series D Preferred Stock. Each share of Series D Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock. For so long as any shares of the Series D Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to two times the sum of all the number of shares of other classes of Corporation capital stock eligible to vote on all matters submitted to a vote of the stockholders of the Corporation. As of December 31, 2024, and September 30, 2024, there were 50,000 shares of Series D Preferred Stock issued and outstanding. Series E Preferred Stock On June 2, 2021, the Company filed a Certificate of Designation with the State of Nevada. Under the terms of the Certificate of Designation 13,650,000 (as amended on June 10, 2021) were designated as Series E Preferred Stock. Each share of Series E Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock. For so long as any shares of the Series E Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote one share on all matters submitted to a vote of the stockholders of the Corporation. As of December 31, 2024, and September 30, 2024, there were no shares of Series E Preferred stock issued and outstanding. Series F Preferred Stock On November 24, 2021, the Company filed a Certificate of Designation with the State of Nevada. Under the terms of the Certificate of Designation 59,270,000 were designated as Series F Preferred Stock. Each share of Series F Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock at any time by the holder. For so long as any shares of the Series F Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote one share on all matters submitted to a vote of the stockholders of the Corporation. The Series F Preferred Stock automatically converts to common stock after the shares of common stock closing market price is at least $0.20 for twenty (20) consecutive trading days. As of December 31, 2024, and September 30, 2024, there were no shares of Series F Preferred stock issued and outstanding. Stock Options The Company did not issue any stock options during the three months ended December 31, 2024. On February 1, 2023, pursuant to a three-year consulting agreement, the Company granted an option to SGG (a related party, the representative of which is the Company’s COO ) to purchase 10,000,000 shares of common stock with an exercise price of $0.02 and an expiration date of July 1, 2025. The options vest over a two-year period at the rate of 25% every six months beginning on the six-month anniversary date of the agreement. The Company valued the option at $639,543 and will amortize the value over the three-year term of the agreement. For the three months ended December 31, 2024, and 2023, no options vested. On March 3, 2023, pursuant to a one-year consulting agreement, the Company granted an option to a third party to purchase 10,000,000 shares of common stock with an exercise price of $0.02 and an expiration date of July 1, 2025. The options vest over a two-year period at the rate of 25% every six months beginning on the six-month anniversary date of the agreement. The Company valued the option at $449,651 and amortized the value over the one-year term of the agreement. For the three months ended December 31, 2024, and 2023, no options vested. The following table summarizes activities related to stock options of the Company for the three months ended December 31, 2024, and the year ended September 30, 2024. There was no activity for the three months ended December 31, 2024. Number of Options Weighted- Average Exercise Price per Share Weighted- Average Remaining Life (Years) Outstanding at October 1, 2023 20,000,000 $ 0.02 1.75 Outstanding at September 30, 2024 20,000,000 $ 0.02 0.75 Exercisable at September 30, 2024 15,000,000 $ 0.02 - Outstanding at December 31, 2024 20,000,000 $ 0.02 0.50 Exercisable at December 31, 2024 15,000,000 $ 0.02 - As of December 31, 2024, and September 30, 2024, 5,000,000 options to purchase shares of common stock remain unvested and $230,946 and $284,241, respectively, of stock compensation expense remains unrecognized and is being expensed over a weighted average period of 2.37 years from the date of the grant. Warrants On April 1, 2024, pursuant to a consulting agreement, the Company issued a warrant to a third party to purchase 50,000 shares of RM Stock that vested immediately and with an exercise price of $1.50 and an expiration date of April 1, 2025. The Company valued the warrant at $119,348 based on the Black Scholes option pricing model and expensed when granted. The following assumptions were utilized in the Black-Scholes valuation of this immediately vested warrant during the year ended September 30, 2024, risk free interest rate of 5.03%, volatility of 145% and an exercise price of $1.50. On February 1, 2023, pursuant to a three-year consulting agreement, the Company granted a warrant to a related party (SGG) to purchase 250,000 shares of RM common stock with an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the warrant at $624,458 and will amortize the value over the three-year term of the agreement. For the three months ended December 31, 2024, and 2023, the Company has included $52,038 in stock-based compensation expense-related party, respectively. On February 8, 2023, an investor paid $5,000 to acquire a warrant to purchase 2,000,000 shares of common stock. The warrant has an exercise price of $0.02 per share and expires July 1, 2024. The Company also issued a warrant to purchase 100,000 shares of RM Stock, with an exercise price of $1.00 and an expiration date of July 1, 2025, as amended. On February 10, 2023, pursuant to a convertible note with a current shareholder of the Company, the Company issued a warrant to the investor to purchase 2,000,000 shares of common stock at an exercise price of $0.025 per share and an expiration date of July 1, 2025. The Company valued the warrant at $79,914, based on the Black Scholes option pricing model. The Company also issued a warrant to purchase 100,000 shares of RM Stock at an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the RM Stock warrant at $249,811, based on the Black Scholes option pricing model. The Company applied $43,416 to the note as a discount based on the allocations of the fair values of the warrants and the note. The Company charged the note discount to interest expense over the term of the note. For the three months ended December 31, 2023, the Company recorded interest expense of $7,662. The note discount was fully amortized as of September 30, 2024. On March 1, 2023, an investor paid $5,000 to acquire a warrant to purchase 2,000,000 shares of common stock. The warrant has an exercise price of $0.02 per share and expires July 1, 2024. The Company also issued a warrant to purchase 100,000 shares of RM Stock, with an exercise price of $1.00 and an expiration date of July 1, 2025, as amended. On March 3, 2023, pursuant to a convertible note with a current shareholder of the Company, the Company issued a warrant to the investor to purchase 2,000,000 shares of common stock at an exercise price of $0.025 per share and an expiration date of July 1, 2025. The Company valued the warrant at $89,916, based on the Black Scholes option pricing model. The Company also issued a warrant to purchase 100,000 shares of RM Stock at an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the RM Stock warrant at $249,822, based on the Black Scholes option pricing model. The Company applied $43,585 to the note as a discount based on the allocations of the fair values of the warrants and the note. The Company charged the note discount to interest expense over the term of the note. For the three months ended December 31, 2023, the Company recorded interest expenses of $7,692. The note discount was fully amortized as of September 30, 2024. On March 3, 2023, pursuant to a one-year consulting agreement with a Company shareholder, the Company issued to the shareholder a warrant to purchase 250,000 shares of RM Stock with an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the warrant at $624,556 and amortized the value over the one-year term of the agreement. For the three months ended December 31, 2023, the Company has included $156,139 in stock-based compensation expenses. The warrant value was fully amortized as of September 30, 2024. The following table summarizes activities related to warrants of the Company for the three months ended December 31, 2024, and the year ended September 30, 2024. Number of Warrants Weighted Average Exercise Price Per Share Weighted Average Remining Life (Years) Outstanding and exercisable at October 1, 2023 8,000,000 $ 0.0225 1.25 Expired or cancelled or forfeited (4,000,000 ) 0.0200 - Outstanding and exercisable at September 30, 2024 4,000,000 $ 0.0250 0.75 Outstanding and exercisable at December 31, 2024 4,000,000 $ 0.0250 0.50 The following table summarizes activities related to warrants to purchase RM Stock from the Company for three months ended December 31, 2024, and the year ended September 30, 2024. Number of Warrants Weighted Average Exercise Price Per Share Weighted Average Remining Life (Years) Outstanding and exercisable at October 1, 2023 900,000 $ 1.00 1.53 Issued 50,000 1.50 1.00 Outstanding and exercisable at September 30, 2024 950,000 $ 1.03 0.74 Outstanding and exercisable at December 31, 2024 950,000 $ 1.03 0.49

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Dec. 31, 2024
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 9 - COMMITMENTS AND CONTINGENCIES The Company does not have an existing contract with the CEO. The monthly compensation and any bonus amounts are at the discretion of the Board of Directors. Effective January 1, 2023, the Company agreed to compensate the CEO $15,000 per month. Effective February 1, 2023, the Company entered a Consulting Executive Officer Agreement with a three- year term to an entity (SGG) to provide the services of a Chief Operating Officer (the “COO”) of the Company. On October 1, 2023, the BOD also appointed the COO as the President. Pursuant to the agreement, the Company agreed to a monthly fee of $10,000, and the issuance of 250,000 common shares per month, to be issued semi-annually. The monthly fee was increased to $15,000 per month effective September 1, 2023. For the three months ended December 31, 2024, and 2023, the Company recorded expenses of $18,450 and $17,875, respectively, related to the 250,000 common shares per month, calculated based on the closing market price of the common stock on the last day of each month. On May 8, 2024, the Company issued 3,000,000 shares of common stock for the months of February 2023, through January 2024. On May 11, 2023, the Company issued 5,000,000 shares to the Company’s COO as a bonus pursuant to their Consulting Agreement. On July 10, 2023, the Company issued 15,000,000 shares to the Company’s COO as a bonus pursuant to their Consulting Agreement. On September 7, 2023, the Company issued 5,000,000 shares to the Company’s COO as a bonus pursuant to their Consulting Agreement. Additionally, the Company granted an option to SGG, a related party (the representative of which is the Company’s COO), to purchase 10,000,000 shares of the Company’s common stock at $0.02 per share with an expiry date of July 1, 2025 (the "CYCA Option”). The CYCA option vests at the rate of 25% beginning on the first six-month anniversary of the agreement, as well as a warrant to purchase 250,000 shares of the Reticulate Micro common stock the Company owns (the “RM Warrant”). The RM Warrant has an exercise price of $1.00 per share and an expiry date of July 1, 2025. The Company valued the CYCA Option at $639,543 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $53,295, is included in stock-based compensation expense-related party for the three months ended December 31, 2024, and 2023, respectively. The Company valued the RM Warrant at $624,458 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $52,038, is included in stock-based compensation expense-related party for the three months ended December 31, 2024, and 2023, respectively. On March 3, 2023, the Company entered a Consulting Agreement with an investor. Pursuant to the agreement, the Company issued 2,000,000 shares of common stock for one year of services. The Company valued the shares at $80,000 based on the price of the common stock on the date the Company agreed to issue the common stock. The Company also issued the consultant 1) an option to purchase 10,000,000 shares of the Company’s common stock at an exercise price of $0.02 per share with an expiry date of July 1, 2025. The options vest over the two-year period in 25% increments beginning on the six- month anniversary of the agreement and 2) a warrant to purchase 250,000 shares of RM Stock at an exercise price of $1.00 per share with an expiry date of July 1, 2025. The option to purchase the Company’s common stock was valued at $449,651 based on the Black Scholes option pricing model and was amortized over the one-year term of the agreement. For the three months ended December 31, 2023, $112,413 is included in stock-based compensation expense and this option value was fully amortized as of September 30, 2024. The warrant to purchase the RM Stock was valued at $624,556 based on the Black Scholes option pricing model and was amortized over the one-year term of the agreement. For the three months ended December 31, 2023, $156,139 is included in stock-based compensation expense and this warrant value was fully amortized as of September 30, 2024. On December 6, 2023, the Company agreed to issue an additional 6,000,000 shares of common stock. The Company valued the 6,000,000 shares at $0.0282 per share and included stock-based compensation expense of $169,200 for the three months ended December 31, 2023. On April 1, 2023, the Company entered a Consulting Agreement with a third party for marketing services in exchange for 250,000 shares of restricted common stock. The shares vest in 12 equal amounts of 20,833. For the three months ended December 31, 2023, the Company has recorded stock-based compensation of $3,006 with the offset to accounts payable and accrued expenses. On October 1, 2023, the Company entered into a one-year Agreement for Board of Advisor Services with a third party to provide general technical, AI, sales, and marketing services in exchange for 3,000,000 shares of common stock. The Company valued the shares at $80,700 ($0.0269 per share). The shares are to be issued at the end of the term, and the Company is amortizing the expense over the term of the contract. For the three months ended December 31, 2023, the Company included $20,175 in General and Administrative expenses and in accounts payable and accrued expenses. Effective May 1, 2024, the Company amended the October 1, 2023 agreement and agreed to issue 7,000,000 shares, of which 5,000,000 were immediately earned and were issued May 16, 2024, and to issue an additional 2,000,000 shares at the end of the term. The Company valued and expensed the 5,000,000 shares at $142,500 ($0.0285 per share) on the date of the agreement, and the Company is amortizing the expense related to the 2,000,000 shares (valued at $57,000) over the term of the contract. For the three months ended December 31, 2024, the Company included $14,250 in General and Administrative expenses and $14,250 in accounts payable and accrued expenses. On January 1, 2024, the Company entered into a one-year Consulting Agreement with a third party to provide market awareness services and the identification, evaluation, structuring, negotiating, and closing of joint ventures, strategic alliances, and business acquisitions, in exchange for 3,000,000 shares of common stock. The Company valued the shares at $62,400 and is amortizing the expense over the term of the contract. For the three months ended December 31, 2024, the Company included $15,600 in General and Administrative expenses. On January 2, 2024, the Company entered into a one-year Consulting Agreement with a third party to provide market awareness services and the identification, evaluation, structuring, negotiating, and closing of joint ventures, strategic alliances, and business acquisitions, in exchange for a monthly fee of $10,000 per month and 5,000,000 shares of common stock. The shares were issued on January 18, 2024. The Company valued the shares at $104,000 and is amortizing the expense over the term of the contract. For the three months ended December 31, 2024, the Company included $26,000 in General and Administrative expenses. On April 1, 2024, the Company entered an Agreement for Board of Advisor Services with a third party to provide general business, military, governmental, technical, AI, and sales and marketing services, in exchange for 2,500,000 shares of common stock upon execution of the agreement (the “Initial Issuance”) and a further 2,500,000 shares of common stock one year after the execution (the “Final Issuance”). The Initial Issuance of 2,500,000 shares of common stock were issued on May 8, 2024. The Company valued the 5,000,000 shares at $137,500 among which $68,750 related to Initial Issuance and is amortizing over the term of the contract. For the three months ended December 31, 2024, the Company included $34,375 in General and Administrative expenses, including the amortization of prepaid expenses of $17,187 (Initial Issuance) and $17,188 accrued in accounts payable and accrued expenses (Final Issuance). In connection with the agreement, the Company also agreed to issue a warrant to purchase 50,000 Class A common stock shares of RM Stock owned by the Company, at $1.50 per share and vested immediately. The warrant to purchase the RM Stock was valued at $119,348 based on the Black Scholes option pricing model and was expensed when granted. On April 23, 2024, the Company entered an Agreement for Board of Advisor Services with a third party to provide assistance to the Company in building its in house development team and manage software projects, in exchange for 3,000,000 shares of common stock. The Company issued 1,500,000 shares of common stock on May 8, 2024, with the balance due on the one-year anniversary of the agreement. The Company valued the 3,000,000 shares at $67,500 among which $33,750 related to the already issued common shares and is amortizing over the term of the contract. For the three months ended December 31, 2024, the Company included $16,875 in General and Administrative expenses, including the amortization of prepaid expenses of $8,437 and $8,438 accrued in accounts payable and accrued expenses. On April 23, 2024, the Company entered an Agreement for Board of Advisor Services with a third party to provide general business, military, governmental, technical, AI, and sales and marketing services, in exchange for 5,000,000 shares of common stock. The Company issued 2,500,000 shares of common stock on May 8, 2024, with the balance due on the one-year anniversary of the agreement. The Company valued the 5,000,000 shares at $112,500 among which $56,250 relates to the already issued common shares and is amortizing over the term of the contract. For the three months ended December 31, 2024, the Company included $28,125 in General and Administrative expenses, including the amortization of prepaid expenses of $14,063 and $14,062 accrued in accounts payable and accrued expenses.

LICENSE AGREEMENT

LICENSE AGREEMENT	3 Months Ended
	Dec. 31, 2024
LICENSE AGREEMENT
LICENSE AGREEMENT	NOTE 10 - LICENSE AGREEMENT On August 9, 2022, the Company signed an Intellectual Property License Agreement (the “IPLA”) with Reticulate Micro, Inc. (“RM”). Pursuant to the ten-year term (the “Term”) of IPLA, RM agreed to issue to the Company 5,100,000 shares of RM’s Class A Common Stock and a royalty of 5% of net sales during the Term in exchange for the licensing of the Company’s technology related to its SUPR ISR (the Superior Utilization of Processing Resources- Intelligence, Surveillance and Reconnaissance). RM, a Nevada corporation, was formed on June 22, 2022. Mr. Collins, the Company’s’ former CTO was a co-founder, and a former Director and President and Treasurer of RM. Mr. Chermak, the Company’s former COO is a co-founder, Director and Vice-president and Secretary of RM. Mr. Ansari is a co-founder and former Director of RM. RM had initially issued 1,600,000, 1,000,000 and 1,000,000 shares of Class B Common Stock to Mr. Collins. Mr. Chermak and Mr. Ansari, respectively. On May 15, 2023, Mr. Collins cancelled his 1,600,000 shares of Class B common stock in exchange for 200,000 shares of Class A common stock. As of December 31, 2024, and September 30, 2024, RM has 2,000,000 and 2,000,000 Class B Common Stock shares outstanding, respectively. Each share of the Class B Common Stock has voting rights whereby each share of Class B Common Stock equals 100 voting shares. As of December 31, 2024, and September 30, 2024, RM had 10,479,431 and 10,459,199 Class A common stock shares issued and outstanding, respectively. As of December 31, 2024, the Company has agreed to issue 1,798,767 shares of RM stock (1,780,531 has been issued and an additional 18,236 shares to be issued) in satisfaction of $2,369,500 of principal of convertible notes and $84,888 of accrued interest. The Company also issued 45,000 shares of RM stock in satisfaction of note payable (principal and interest). Accordingly, as of December 31, 2024, and September 30, 2024, the Company’s 3,301,233 shares of RM Class A Common Stock represent approximately 1.57%, respectively of the voting stock of RM. Each share of the Class B Common stock is also convertible into one share of Class A Common Stock. The Company accounts for its interest in RM under the cost method of accounting. Due to RM just being formed at the time of the license agreement no value has been assigned to the investment.

INCOME TAXES

INCOME TAXES	3 Months Ended
	Dec. 31, 2024
INCOME TAXES
INCOME TAXES	NOTE 11 - INCOME TAXES The Company provides for income taxes under ASC 740, Accounting for Income Taxes. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. ASC 740 requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future income, management has determined that the deferred tax assets do not meet the more-likely-than-not threshold for realizability. Accordingly, there is a full valuation allowance provided against the Company’s deferred tax assets as of December 31, 2024 and September 30, 2024. A reconciliation of the provision for income taxes determined at the U.S. statutory rate to the Company’s effective income tax rate is as follows: Three months ended December 31, 2024 Three months Ended December 31, 2023 Pre-tax loss $ (687,143 ) $ (1,059,128 ) U.S. federal corporate income tax rate 21 % 21 % Expected U.S. income tax credit (144,300 ) (222,417 ) Permanent differences 54,394 125,898 Change of valuation allowance 89,906 96,519 Effective tax expense $ — $ — The Company had deferred tax assets as follows: December 31, 2024 September 30, 2024 Net operating losses carried forward $ 2,535,257 $ 2,445,350 Less: Valuation allowance (2,535,257 ) (2,445,350 ) Net deferred tax assets $ — $ — As of December 31, 2024, and September 30, 2024, the Company has approximately $12,073,000 and $11,645,000, respectively, net operating loss carryforwards available to reduce future taxable income. As of December 31, 2024, and September 30, 2024, the Company has no material unrecognized tax benefits which would favorably affect the effective income tax rate in future periods and does not believe that there will be any significant increases or decreases of unrecognized tax benefits within the next twelve months. No interest or penalties relating to income tax matters have been imposed on the Company during the three months ended December 31, 2024, and 2023, and no provision for interest and penalties is deemed necessary as of December 31, 2024, and September 30, 2024.

DEFERRED REVENUE

DEFERRED REVENUE	3 Months Ended
	Dec. 31, 2024
DEFERRED REVENUE
DEFERRED REVENUE	NOTE 12 - DEFERRED REVENUE During the three months ended December 31, 2024, and 2023, the Company delivered $230,835 and $-0- in the aggregate of software services to customers under one year subscription periods. The Company records the agreed amounts over the one-year term of the subscription agreements as deferred revenue, classified as a liability on the balance sheet, and amortizes the deferred revenue over the subscription period. For the three months ended December 31, 2024, and 2023, the Company recognized $38,225 and $2,411 of revenue from these agreements, respectively. As of December 31, 2024, and September 30, 2024, the balance of deferred revenues of $195,524 and $2,914 is included in the balance sheet, respectively.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Dec. 31, 2024
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 13 - SUBSEQUENT EVENTS On January 27, 2025, the Company issued 180,000 shares of common stock in satisfaction of $4,500 of accrued interest. On January 31, 2025, the Company issued 180,000 shares of common stock in satisfaction of $4,500 of accrued interest. From January 22, 2025, through February 7, 2025, noteholders of the aggregate of $1,133,000 of principal of convertible notes payable and $195,740 of accrued and unpaid interest executed Notices of Conversion whereby they will receive 884,955 shares of RM Class A common stock owned by the Company, in full satisfaction of their notes. The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Dec. 31, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of December 31, 2024, and the results of operations and cash flows for the periods presented. The results of operations for the three months ended December 31, 2024, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited financial statements should be read in conjunction with the audited financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K filed on January 14, 2025, for the year ended September 30, 2024.
Use of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.
Reclassifications	Certain prior period amounts have been reclassified to conform with the current period presentation.
Cash and Cash Equivalents	The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits of $250,000 per financial institution. The amount in excess of the FDIC insurance as of December 31, 2024, was approximately $750,000. The Company has no cash equivalents at December 31, 2024, and September 30, 2024.
Prepaid expenses	The Company considers expenses or services paid for prior to the period the expense is incurred to be recorded as a prepaid expense. Included in this account is the value of common stock, options and warrants issued to consultants. Such issuances are pursuant to consulting agreements that can have a one-to-two-year term. The Company amortized the value of the stock issued over the term of the agreement. The activity for the three months ended December 31, 2024, and 2023 is summarized as: December 31, 2024 2023 Balance beginning of period $ 684,489 $ 1,548,752 Amortization of stock-based compensation (186,621 ) (389,260 ) Other prepaid expense activity 11,746 (63,285 ) Sub-total 509,614 1,096,207 Less non-current portion (all related party) 35,109 456,443 Prepaid expenses, current portion 474,505 639,764 Less prepaid expenses – related party, current portion 421,334 421,334 Prepaid expenses – other, current portion $ 53,171 $ 218,430
Property and equipment	Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets. The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows: Vehicles and equipment 5 years Software 3 years
Convertible Instruments	The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. In August 2020, the FASB issued Accounting Standards Update 2020-06 (ASU 2020-06). ASU 2020-06 eliminates the beneficial conversion feature and cash conversion models in Accounting Standards Codification 470-20 that require separate accounting for embedded conversion features in convertible instruments. The new guidance also eliminates some of the conditions that must be met for equity classification under ASC 815-40-25. The standard is effective for smaller reporting companies for annual periods beginning after December 15, 2023. Early adoption is permitted. The Company chose to early adopt this standard. As a result, financial results contained herein are reported in accordance with this standard as applicable. The convertible debt issued by the Company referred to in Note 7, did not require separate accounting for the conversion feature as it was not considered to be a derivative. The Company issued warrants in connection with the debt financing and in accordance with ASC 470-20-25-2 the proceeds from the sale of the debt instruments have been allocated to the debt and warrants based on the relative fair value of the two components. The amount allocated to the warrants has been recorded as a debt discount to be amortized of the life of the note.
Fair value of financial instruments	The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: ● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities. ● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, accounts payable and accrued expenses, related party liabilities, and deferred revenue, approximate their fair values because of the short maturity of these instruments.
Revenue recognition	Our revenues are primarily generated from fees charged in connection with the implementation of our software platform (including the sale of SaaS products and services, maintenance associated with the sale of on premise software licenses). Our revenue recognition policy follows the guidance from Accounting Standards Codification (“ASC”) 606, “Revenue Recognition,” and Accounting Standards Update No. 2014-09 – Revenue from Contracts with Customers (Topic 606) which provide guidance on the recognition, presentation, and disclosure of revenue in financial statements. We determine revenue recognition through the following steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract and (v) recognition of revenue when a performance obligation is satisfied. Revenue from fees charged in connection with the implementation of our software platform is recognized ratably over the term specified with the customers, which is primarily one year. The transaction price is the amount of consideration to which the Company expects to be entitled to receive in exchange for providing access to its platform. Maintenance and support services generally call for the Company to provide software updates and technical support to customers and is recognized ratably over the term of the contract as this is the period the services are delivered. The Company does not view the provision of initial setup services as a discrete earnings event that is distinct. Our standard payment terms are generally no more than 60 days. SaaS and maintenance services are typically invoiced annually in advance. Amounts billed or collected in excess of revenue recognized are included as deferred revenue. For the three months ended December 31, 2024, and 2023, the Company derives all of its revenues from the 1-year license software/hosting package of CyttaComms IGAN v3.0 unlimited channels/users and streams.
Accounts receivable	The Company records accounts receivable at the time services are invoiced when the access to our platform is delivered or provided to the customers. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.
Stock-based compensation	The Company accounts for its stock based compensation under the recognition and measurement principles of the fair value recognition provisions of Statement of Financial Accounting Standards No. 123 (revised 2004) “Share-Based Payment” (ASC 718) using the modified prospective method for transactions in which the Company obtains employee services in share-based payment transactions and the Financial Accounting Standards Board Emerging Issues Task Force Issue No. 96-18 “Accounting For Equity Instruments That Are Issued To Other Than Employees For Acquiring, Or In Conjunction With Selling Goods Or Services” (“EITF No. 96-18”) for share-based payment transactions with parties other than employees provided in (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the grant date.
Income taxes	The Company accounts for income taxes under Statement of Financial Accounting Standards No. 109 “Accounting for Income Taxes” (“SFAS No. 109”) (ASC 740). Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.
Cash flows reporting	The Company follows the provisions of ASC 230 for cash flows reporting and accordingly classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230 to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.
Reporting segments	ASC 280 establishes standards for the way that public enterprises report information about operating segments in annual financial statements and requires reporting of selected information about operating segments in interim financial statements regarding products and services, geographic areas and major customers. ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company’s financial statements as substantially all of the Company’s operations are conducted in one industry segment.
Concentrations of Credit Risk	The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.
Earnings (Loss) Per Share of Common Stock	The Company has adopted ASC 260-10-20, “Earnings per Share,” (“EPS”) which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.
Recent Accounting Pronouncements	There have been no recent accounting pronouncements or changes in accounting pronouncements during the three months ended December 31, 2024, that are of significance or potential significance to the Company.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Dec. 31, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of amortization of the value of the stock issued	December 31, 2024 2023 Balance beginning of period $ 684,489 $ 1,548,752 Amortization of stock-based compensation (186,621 ) (389,260 ) Other prepaid expense activity 11,746 (63,285 ) Sub-total 509,614 1,096,207 Less non-current portion (all related party) 35,109 456,443 Prepaid expenses, current portion 474,505 639,764 Less prepaid expenses – related party, current portion 421,334 421,334 Prepaid expenses – other, current portion $ 53,171 $ 218,430

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	3 Months Ended
	Dec. 31, 2024
PROPERTY AND EQUIPMENT
Schedule of property and equipment	December 31, 2024 September 30, 2024 Property and equipment $ 245,606 $ 245,606 Accumulated depreciation (205,033 ) (194,739 ) Property and equipment, net $ 40,573 $ 50,867

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	3 Months Ended
	Dec. 31, 2024
RELATED PARTY TRANSACTIONS
Schedule of recorded expenses to related parties	Three months ended December 31, 2024 2023 Management fees, Chief Executive Officer (CEO) $ 45,000 $ 45,000 President and Chief Operating Officer (COO) 45,000 45,000 Stock-based compensation expense, officers 123,783 123,208 Office rent and expenses 7,955 - Total $ 221,738 $ 213,208
Schedule of Accounts payable related parties	December 31, 2024 September 30, 2024 Management fees, Chief Executive Officer (CEO) $ 110,000 $ 110,000 Bonus, CEO 48,040 68,040 Stock to be issued President and COO 227,085 208,635 Accounts payable, President and COO 8,872 26,418 Fees, bonus, and accounts payable, former CTO 30,000 30,000 Total $ 423,997 $ 443,093

CONVERTIBLE NOTES PAYABLE (Tabl

CONVERTIBLE NOTES PAYABLE (Tables)	3 Months Ended
	Dec. 31, 2024
CONVERTIBLE NOTES PAYABLE
Schedule of notes payable	December 31, 2024 December 31, 2023 Beginning balance, face value $ 1,438,950 $ 1,215,000 Convertible notes issued - 40,000 Convertible note discount - (32,859 ) Ending balance $ 1,438,950 $ 1,222,141 December 31, 2024 September 30, 2024 March 2023 Convertible notes payable, interest at 18%, $60,000 matures May 31, 2025, and $100,000 matures July 1, 2025 $ 160,000 $ 160,000 December 2023 Convertible note payable, interest at 18%, matures May 31, 2025 40,000 40,000 March 2024 Convertible notes payable, interest at 18%, $250,000 matured January 22, 2025, and $100,000 matures various dates of March 2025 350,000 350,000 June 2024 Convertible notes payable, interest at 18%, matures during quarter ending June 30, 2025 763,950 763,950 September 2024 Convertible notes payable, interest at 18%, matures during quarter ending September 30, 2025 125,000 125,000 Convertible notes payable, balance $ 1,438,950 $ 1,438,950

CAPITAL STOCK (Tables)

CAPITAL STOCK (Tables)	3 Months Ended
	Dec. 31, 2024
CAPITAL STOCK
Schedule of activities related to stock options	Number of Options Weighted- Average Exercise Price per Share Weighted- Average Remaining Life (Years) Outstanding at October 1, 2023 20,000,000 $ 0.02 1.75 Outstanding at September 30, 2024 20,000,000 $ 0.02 0.75 Exercisable at September 30, 2024 15,000,000 $ 0.02 - Outstanding at December 31, 2024 20,000,000 $ 0.02 0.50 Exercisable at December 31, 2024 15,000,000 $ 0.02 -
Schedule of activities related to warrants	Number of Warrants Weighted Average Exercise Price Per Share Weighted Average Remining Life (Years) Outstanding and exercisable at October 1, 2023 8,000,000 $ 0.0225 1.25 Expired or cancelled or forfeited (4,000,000 ) 0.0200 - Outstanding and exercisable at September 30, 2024 4,000,000 $ 0.0250 0.75 Outstanding and exercisable at December 31, 2024 4,000,000 $ 0.0250 0.50 Number of Warrants Weighted Average Exercise Price Per Share Weighted Average Remining Life (Years) Outstanding and exercisable at October 1, 2023 900,000 $ 1.00 1.53 Issued 50,000 1.50 1.00 Outstanding and exercisable at September 30, 2024 950,000 $ 1.03 0.74 Outstanding and exercisable at December 31, 2024 950,000 $ 1.03 0.49

INCOME TAXES (Tables)

INCOME TAXES (Tables)	3 Months Ended
	Dec. 31, 2024
INCOME TAXES
Schedule of provision for income taces	Three months ended December 31, 2024 Three months Ended December 31, 2023 Pre-tax loss $ (687,143 ) $ (1,059,128 ) U.S. federal corporate income tax rate 21 % 21 % Expected U.S. income tax credit (144,300 ) (222,417 ) Permanent differences 54,394 125,898 Change of valuation allowance 89,906 96,519 Effective tax expense $ — $ —
Schedule of deferred tax assets	December 31, 2024 September 30, 2024 Net operating losses carried forward $ 2,535,257 $ 2,445,350 Less: Valuation allowance (2,535,257 ) (2,445,350 ) Net deferred tax assets $ — $ —

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	Dec. 31, 2024	Sep. 30, 2024
GOING CONCERN
Accumulated deficit	$ (37,555,035)	$ (36,867,892)
working capital	$ (1,000,269)

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Dec. 31, 2024	Dec. 31, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Prepaid expenses beginning balance	$ 684,489	$ 1,548,752
Amortization of stock-based compensation	(186,621)	(389,260)
Other prepaid expense activity	11,746	(63,285)
Sub-total	509,614	1,096,207
Less non-current portion (all related party)	35,109	456,443
Prepaid expenses current portion	474,505	639,764
Less prepaid expenses - related party, current portion	421,334	421,334
Prepaid expenses - other, current portion	$ 53,171	$ 218,430

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)	3 Months Ended
	Dec. 31, 2024
Vehicles And Equipment [Member]
Property Plant And Equipment Usefu Life	5 years
Software [Member]
Property Plant And Equipment Usefu Life	3 years

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	Dec. 31, 2024 USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Deposit Insurance Limit	$ 250,000
Amount Exceeding FDIC Limit	$ 750,000

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Dec. 31, 2024	Sep. 30, 2024
PROPERTY AND EQUIPMENT
Property and equipments	$ 245,606	$ 245,606
Accumulated depreciation	(205,033)	(194,739)
Property and equipment, Net	$ 40,573	$ 50,867

PROPERTY AND EQUIPMENT (Detai_2

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
PROPERTY AND EQUIPMENT
Depreciation expenses	$ 10,294	$ 10,576

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
General and administrative - related party	$ 221,738	$ 213,208
Management fees, Chief Executive Officer (CEO) [Member]
General and administrative - related party	45,000	45,000
President and Chief Operating Officer (COO) [Member]
General and administrative - related party	45,000	45,000
Stock Based Compensation Expense Officers [Member]
General and administrative - related party	123,783	123,208
Office Rent and Expenses [Member]
General and administrative - related party	$ 7,955	$ 0

RELATED PARTY TRANSACTIONS (D_2

RELATED PARTY TRANSACTIONS (Details 1) - USD ($)	Dec. 31, 2024	Sep. 30, 2024
RELATED PARTY TRANSACTIONS
Related party liabilities	$ 423,997	$ 443,093
Fees, bonus, and accounts payable, former CTO [Member]
RELATED PARTY TRANSACTIONS
Related party liabilities	30,000	30,000
Accounts payable, President and COO [Member]
RELATED PARTY TRANSACTIONS
Related party liabilities	8,872	26,418
Bonus CEO [Member]
RELATED PARTY TRANSACTIONS
Related party liabilities	48,040	68,040
Management fees, Chief Executive Officer (CEO) [Member]
RELATED PARTY TRANSACTIONS
Related party liabilities	110,000	110,000
Stock to be issued President and COO [Member]
RELATED PARTY TRANSACTIONS
Related party liabilities	$ 227,085	$ 208,635

RELATED PARTY TRANSACTIONS (D_3

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)		3 Months Ended
	Sep. 07, 2023	Dec. 31, 2024	Dec. 31, 2023	Sep. 30, 2024
Amortizatization expences		$ 624,458
Purchase of common stock shares	5,000,000
Common stock price per share			$ 0.0282
General and administrative - related party		221,738	$ 213,208
Stock-based compensation		123,783	123,208
Related party liabilities		423,997		$ 443,093
Consulting Executive Officer Agreement [Member]
Compensation and related costs monthly		$ 10,000
Issuance of common stock shares per month		250,000
Purchase of common stock shares		10,000,000
Common stock price per share		$ 0.02
Expiry date		Jul. 01, 2025
Warrant to purchase of common stock		250,000
Warrant exercise price		$ 1
Consulting Executive Officer Agreement [Member] | February 1, 2023 [Member]
Purchase of common stock shares		250,000
Stock-based compensation		$ 18,450	17,875
Consulting Executive Officer Agreement [Member] | January 1, 2023 [Member]
Compensation and related costs monthly		15,000
Black Scholes Option 1 [Member]
Amortizatization expences		624,458
Stock-based compensation		52,038	52,038
Black Scholes Option [Member]
Amortizatization expences		639,543
Stock-based compensation		53,295	53,295
President and Chief Operating Officer (COO) [Member]
Compensation and related costs monthly		15,000
General and administrative - related party		45,000	$ 45,000
Chief Operating Officer [Member]
General and administrative - related party		7,955
Monthly rent for office space		$ 2,575

NOTE PAYABLE (Details Narrative

NOTE PAYABLE (Details Narrative) - USD ($)	Jan. 10, 2024	Jan. 10, 2023
NOTE PAYABLE
Interest rate	8%	8%
Proceeds from debt or equity, amount		$ 1,000,000
Debt instrument face amount		$ 40,000
Debt instrument collateral, description	On August 12, 2024, the Company has agreed to transfer 45,000 shares of RM stock to RM (the lender) for satisfaction of the note and accrued and unpaid interest
Collateral Pledged Shares	45,000
Maturity date	Jul. 10, 2024	Jan. 10, 2024
Debt instrument principal balance	$ 43,200

CONVERTIBLE NOTES PAYABLE (Deta

CONVERTIBLE NOTES PAYABLE (Details) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
CONVERTIBLE NOTES PAYABLE
Beginning balance	$ 1,438,950	$ 1,215,000
Convertible notes issued	0	40,000
Convertible note discount amount	0	(32,859)
Ending balance	$ 1,438,950	$ 1,222,141

CONVERTIBLE NOTES PAYABLE (De_2

CONVERTIBLE NOTES PAYABLE (Details 1) - USD ($)	3 Months Ended				12 Months Ended
	Dec. 31, 2024	Jun. 30, 2024	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023
Convertible promissory note	$ 1,438,950				$ 1,438,950	$ 1,222,141	$ 1,215,000
March 2023 [Member]
Convertible promissory note				$ 160,000
Interest rate				18%
March 2024 [Member]
Convertible promissory note			$ 517,500
Interest rate			18%
September 2024 [Member]
Convertible promissory note	125,000
Interest rate					18%
June 2024 [Member]
Convertible promissory note		$ 1,910,950
Interest rate		18%
Convertible Debt [Member]
Convertible promissory note	1,438,950				$ 1,438,950
Convertible Debt [Member] | March 2023 [Member]
Convertible promissory note	$ 160,000				160,000
Interest rate	18%
Convertible Debt [Member] | December 2023 [Member]
Convertible promissory note	$ 40,000				40,000
Interest rate	18%
Convertible Debt [Member] | March 2024 [Member]
Convertible promissory note	$ 350,000				350,000
Interest rate	18%
Convertible Debt [Member] | September 2024 [Member]
Convertible promissory note	$ 125,000				125,000
Interest rate	18%
Convertible Debt [Member] | June 2024 [Member]
Convertible promissory note	$ 763,950				$ 763,950
Interest rate	18%

CONVERTIBLE NOTES PAYABLE (De_3

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)			3 Months Ended					12 Months Ended
	Jan. 10, 2024	Jan. 10, 2023	Dec. 31, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Sep. 30, 2024	Feb. 29, 2024	Sep. 30, 2023
Convertible note issued			$ 0			$ 40,000
Amortization of debt discount						7,692
Convertible promissory note			1,438,950			1,222,141		$ 1,438,950		$ 1,215,000
Maturity date	Jul. 10, 2024	Jan. 10, 2024
Convertible Note [Member]
Convertible promissory note							$ 100,000		$ 60,000
March 2024 [Member]
Warrant exercise price					$ 0.025
Stock price					$ 2
Convertible promissory note					$ 517,500
Interest rate					18%
Maturity date					Mar. 31, 2025
Exercise price of stock					$ 2
Amount due to related party								$ 167,500
Issuance of common stock shares								83,750
Debt Instrument, Principal Amount			250,000
Debt Instrument, Total balance amount			350,000
Debt Instrument, Accrued Interest			45,000
Conversion price of RM Stock					$ 2.50
Balance of convertible note			$ 350,000					$ 350,000
March 2024 [Member] | RM Stock [Member]
Convertible promissory note					$ 250,000
Maturity date			Jan. 22, 2025
Debt Conversion into stock			295,000
Remaining Principal Amount			$ 100,000
March 2023 [Member]
Warrant exercise price							$ 0.025
Convertible promissory note							$ 160,000
Interest rate							18%
Maturity date							Jul. 01, 2024
Exercise price of stock							$ 1
Balance of convertible note			160,000					160,000
March 2023 [Member] | RM stock Note One [Member]
Convertible note issued							$ 50,000
Purchase of warrants							2,000,000
Warrant exercise price							$ 0.025
Additional warrant to purchase							100,000
Stock price							$ 1
Expiration date							July 1, 2025
March 2023 [Member] | RM Stock Another Note 2 [Member]
Convertible note issued							$ 50,000
Purchase of warrants							2,000,000
Warrant exercise price							$ 0.025
Additional warrant to purchase							100,000
Stock price							$ 1
Expiration date							July 1, 2025
Debt discounts			43,585				$ 43,416
Amortization of debt discount						$ 7,662
Convertible notes payable, net of discount			160,000
December 2023 [Member]
Warrant exercise price						$ 0.025
Stock price						$ 1
Convertible promissory note						$ 40,000
Interest rate						18%
Maturity date						Dec. 31, 2024
Exercise price of stock						$ 1
Balance of convertible note			$ 40,000					$ 40,000
June 2024 [Member]
Warrant exercise price			$ 0.025	$ 0.025
Convertible promissory note				$ 1,910,950
Interest rate				18%
Maturity date				Jun. 30, 2025
Exercise price of stock			$ 2	$ 2
Issuance of common stock shares				573,500
Amount due to related party				$ 1,147,000
Balance of convertible note				763,950
June 2024 [Member] | RM Stock [Member]
Convertible promissory note			$ 15,000	$ 85,000
September 2024 [Member]
Warrant exercise price								$ 0.025
Stock price								$ 2
Convertible promissory note			$ 125,000
Interest rate								18%
Maturity date								Sep. 30, 2025
Exercise price of stock			$ 1					$ 2
Balance of convertible note			$ 125,000					$ 125,000

CAPITAL STOCK (Details)

CAPITAL STOCK (Details) - Stock Options [Member] - $ / shares	3 Months Ended	12 Months Ended
	Dec. 31, 2024	Sep. 30, 2024
Outstanding, beginning balance	20,000,000	20,000,000
Issued	20,000,000
Outstanding, ending balance	20,000,000	20,000,000
Number of options outstanding exercisable	15,000,000	15,000,000
Weighted average exercise price, beginning balance	$ 0.02	$ 0.02
Weighted average exercise price, issued	0.02	0.02
Weighted average exercise price, ending balance	0.02	0.02
Weighted average exercise price, exercisable	$ 0.02	$ 0.02
Weighted average remaining term in years, issued	9 months	1 year 9 months
Weighted average remaining term in years, outstanding	6 months	8 months 30 days

CAPITAL STOCK (Details 1)

CAPITAL STOCK (Details 1) - Warrants Member - $ / shares	3 Months Ended	12 Months Ended
	Dec. 31, 2024	Sep. 30, 2024
Outstanding, beginning balance	4,000,000	8,000,000
Expired or cancelled or forfeited		(4,000,000)
Outstanding, ending balance	4,000,000	4,000,000
Weighted average exercise price, beginning balance	$ 0.0250	$ 0.0225
Weighted average exercise price, Expired or cancelled or forfeited	0.0225	0.0200
Weighted average exercise price, ending balance	$ 0.0250	$ 0.0250
Weighted average remaining term in years, Issued	8 months 30 days	1 year 3 months
Weighted average remaining term in years, outstanding and exercisable	6 months	9 months

CAPITAL STOCK (Details 2)

CAPITAL STOCK (Details 2) - Warrants to purchase RM Stock Member - $ / shares	3 Months Ended	12 Months Ended
	Dec. 31, 2024	Sep. 30, 2024
Outstanding, beginning balance	950,000	900,000
Number of share warrants issued		50,000
Outstanding, ending balance	950,000	950,000
Weighted average exercise price, beginning balance	$ 1.03	$ 1
Weighted average exercise price, warrants issued	1.03	1.50
Weighted average exercise price, ending balance	$ 1.03	$ 1.03
Weighted average remaining term in years, issued	8 months 26 days	1 year 6 months 10 days
Weighted average remaining term in years, outstanding and exercisable	5 months 26 days	1 year

CAPITAL STOCK (Details Narrativ

CAPITAL STOCK (Details Narrative) - USD ($)					1 Months Ended		3 Months Ended		12 Months Ended
	Mar. 03, 2023	Mar. 02, 2023	Feb. 10, 2023	Feb. 08, 2023	Mar. 03, 2023	Feb. 02, 2023	Dec. 31, 2024	Dec. 31, 2023	Sep. 30, 2024	Apr. 01, 2024	Dec. 06, 2023	Feb. 01, 2023
Common stock shares, authorized							600,000,000		600,000,000
Preferred stock shares, par value							$ 0.001
Common stock shares, issued							469,877,826		469,877,826		6,000,000
Common stock share, outstanding							469,877,826		469,877,826
Common stock issued for services, amount								$ 169,200
General and administrative - related party							$ 221,738	213,208
Preferred stock, shares authorized							100,000,000		100,000,000
Preferred stock, par value							$ 0.001		$ 0.001
Interest expense								7,692
Consulting Agreement [Member]
Common stock shares, issued	2,000,000				2,000,000						6,000,000	250,000
Expiration date	July 1, 2025						July 1, 2025
Warrants exercise price	$ 0.02				$ 0.02							$ 0.02
Stock Options [Member]
Weighted average remaining term in years, issued							2 years 4 months 13 days
Unrecognized stock compensation expense							$ 230,946		$ 284,241
Share-based payment arrangement, nonvested award, cost not yet recognized, share							5,000,000		5,000,000
Share-based compensation arrangement by share-based payment award					10,000,000	10,000,000
Share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised					$ 0.02	$ 0.02
Vesting percentage					25%	25%
Stock option value					$ 449,651	$ 639,543
Warrants Member | Consulting Agreement [Member]
General and Administrative expenses- related party								156,139
Warrants exercise price	$ 1				$ 1
Fair value of warrant	$ 624,556				$ 624,556
Warrant to purchase shares of RM stock based on black scholes option pricing model, share	250,000				250,000
Warrant [Member]
Warrants or Rights, Expiration Date		July 1, 2025	July 1, 2025	July 1, 2024	July 1, 2025	July 1, 2025	July 1, 2025
General and administrative - related party							$ 52,038	52,038
Warrants exercise price	$ 0.025		$ 0.025	$ 0.02	$ 0.025	$ 1	$ 1
Proceeds from Issuance of Warrants							$ 5,000
Fair value of warrant	$ 89,916	$ 249,822	$ 79,914		$ 89,916	$ 624,458
Warrant to purchase shares of RM stock, shares	100,000		100,000	100,000	100,000		100,000
Warant exercise price RM stock	$ 1		$ 1	$ 1	$ 1
Warrant to purchase share	2,000,000		2,000,000	2,000,000	2,000,000	250,000	2,000,000
Risk free interest rate									5.03%
Volatility									145%
Warrant purchase value							$ 119,348
Exercise price							$ 0.02		$ 1.50
Warrant to purchase shares of RM Stock based on Black scholes option pricing Model, value			$ 249,811
Discount amount based on allocations	$ 43,585		$ 43,416		$ 43,585
Interest expense								7,662
Payment to acquire warrants				$ 5,000
April 1, 2024 | Warrants Member | Consulting Agreement [Member]
Warrants exercise price										$ 1.50
Warrant to purchase shares of RM stock based on black scholes option pricing model, share										50,000
Series F Preferred Stock [Member]
Preferred stock, shares authorized							59,270,000		59,270,000
Accounts payable related parties									$ 47,269
Preferred stock, par value							$ 0.001		$ 0.001
Preferred stock shares issued							0		0
Preferred stock shares outstanding							0		0
Price per share									$ 0.20
Series C Preferred Stock [Member]
Preferred stock, shares authorized							12,000,000		12,000,000
Preferred stock, par value							$ 0.001		$ 0.001
Designated preferred shares							12,000,000
Preferred stock shares issued							600,000		600,000
Preferred stock shares outstanding							600,000		600,000
Series D Preferred Stock [Member]
Preferred stock, shares authorized							10,000,000		10,000,000
Preferred stock, par value							$ 0.001		$ 0.001
Preferred stock shares issued							50,000		50,000
Preferred stock shares outstanding							50,000		50,000
Series E Preferred Stock [Member]
Preferred stock, shares authorized							13,650,000		13,650,000
Preferred stock, par value							$ 0.001		$ 0.001
Preferred stock shares issued							0		0
Preferred stock shares outstanding							0		0
Common Stocks [Member] | Subscription Agreement [Member]
Expiration date			July 1, 2025
Common Stocks [Member] | December 31, 2023 [Member]
Common stock issued for services, shares							6,000,000
Common stock issued for services, amount							$ 169,200
Common Stocks Share [Member]
Common stock issued for payment of account payable share							1,887,750
Common stock issued for payment of account payable amount							$ 46,826
Common stock issued settlement of stock payable							$ 50,781
Gain on debt extinguishment								$ 3,955
Common Stock [Member]
Common stock shares, authorized							600,000,000		600,000,000
Common stock shares, par value							$ 0.001		$ 0.001
Common stock shares, issued							469,877,826		469,877,826
Common stock share, outstanding							469,877,826		469,877,826

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)					1 Months Ended		3 Months Ended
	May 07, 2024	Apr. 02, 2024	Sep. 07, 2023	Mar. 03, 2023	May 16, 2024	Apr. 23, 2024	Dec. 31, 2024	Dec. 31, 2023	Sep. 30, 2024	May 08, 2024	Apr. 01, 2024	Dec. 06, 2023	Jul. 10, 2023	May 11, 2023	Apr. 01, 2023	Feb. 01, 2023
Purchase of common stock shares			5,000,000
Stock-based compensation expense							$ 112,413	$ 169,200
Common stock price per share								$ 0.0282
Common stock shares issued							469,877,826		469,877,826			6,000,000
Stock-based compensation							$ 123,783	$ 123,208
Stock-based compensation expense-related party								156,139
General and administrative - related party							221,738	213,208
Amortizatization expences							624,458
Purchase of warrant value				$ 449,651
Common stock to be issued	3,000,000
Consulting Executive Officer Agreement [Member]
General and administrative - related party							52,038	52,038
Compensation and related costs monthly							15,000
Investor Awareness Advisory Services Agreement [Member]
Warrants exercise price				$ 1												$ 1
Expiry date				Jul. 01, 2025
Consulting Agreement [Member]
Common stock shares issued				2,000,000								6,000,000				250,000
Stock-based compensation							18,450	17,875
Monthly fee																$ 10,000
Issuance of restricted common stock shares																10,000,000
Initial shares issued				10,000,000												250,000
Warrants exercise price				$ 0.02												$ 0.02
Voting stock percentage				25%												25%
Compensation and related costs monthly							$ 15,000
Issuance of common stock shares per month							250,000
Amortizatization expences							$ 639,543
Purchase of warrants				624,556
Warrant issued				250,000
Expiry date				July 1, 2025			July 1, 2025
Number of share valued based on price of common stock				$ 80,000
Consulting Agreement [Member] | COO [Member]
Stock-based compensation							$ 53,295	53,295
Share issued														5,000,000
Share-based payment arrangement, nonvested award, cost not yet recognized, share													15,000,000
Consulting Agreement [Member] | April 1, 2023 [Member]
Stock-based compensation								$ 3,006
Issuance of restricted common stock shares															250,000
Shares vest in equal amounts															20,833
Marketing Services Agreement [Member] | October 1, 2023 [Member]
Common stock price per share									$ 0.0269
General and administrative - related party							$ 20,175
Common stock to be issued							3,000,000
Common stock to be issued, value							$ 80,700
Marketing Services Agreement [Member] | January 1, 2024 [Member]
General and administrative - related party							$ 15,600
Common stock to be issued							3,000,000
Common stock to be issued, value							$ 62,400
Marketing Services Agreement [Member] | January 2, 2024 [Member]
Monthly fee							10,000
General and administrative - related party							$ 26,000
Common stock to be issued							5,000,000
Common stock to be issued, value							$ 104,000
Marketing Services Agreement [Member] | May 1, 2023 [Member]
General and administrative - related party							14,250
Accounts payable and accrued expenses expences							$ 14,250
Description for the agreement of advisor services					The Company valued and expensed the 5,000,000 shares at $142,500 ($0.0285 per share) on the date of the agreement, and the Company is amortizing the expense related to the 2,000,000 shares (valued at $57,000) over the term of the contract
Common stock to be issued					5,000,000		7,000,000
Additional Common stock to be issued					2,000,000
Agreement for Board of Advisor Services [Member]
Common stock issued for settlement of accrued interest						3,000,000				1,500,000
Initial issuance of common stock shares						5,000,000	3,000,000			2,500,000	2,500,000
Further share issued											2,500,000
General and administrative - related party							$ 34,375
Amortizing initial issuance value							68,750
Accounts payable and accrued expenses expences							17,188
Amortization of prepaid expenses							17,187
Warrant to purchase, value											$ 119,348
Initial issuance of common stock, value		$ 137,500				$ 67,500	$ 112,500
Agreement for Board of Advisor Services [Member] | Class A [Member]
Common stock price per share											$ 1.50
Initial issuance of common stock shares						5,000,000	5,000,000
Amortization of prepaid expenses							$ 14,063
Purchase of warrants											50,000
Initial issuance of common stock, value							56,250
Agreement for Board of Advisor Services [Member] | April 23, 2024 [Member]
General and administrative - related party							16,875
Accounts payable and accrued expenses expences							8,438
Agreement for Board of Advisor Services [Member] | April 23, 2024 One [Member]
Common stock shares issued										2,500,000
General and administrative - related party							28,125
Accounts payable and accrued expenses expences							14,062
Amortization of prepaid expenses							8,437
Initial issuance of common stock, value							$ 33,750

LICENSE AGREEMENT (Details Narr

LICENSE AGREEMENT (Details Narrative) - USD ($)		3 Months Ended
	Aug. 09, 2022	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023	Dec. 06, 2023	Sep. 30, 2023	May 15, 2023	Jun. 22, 2022
Common Stock shares outstanding		469,877,826	469,877,826
Common stock shares issued		469,877,826	469,877,826		6,000,000
Convertible promissory note		$ 1,438,950	$ 1,438,950	$ 1,222,141		$ 1,215,000
Common Stock Class B [Member] | Mr Collins [Member]
Common stock shares issued								1,600,000
Cancellation of common stock							1,600,000
Total number of share exchanged							200,000
Common Stock Class B [Member] | Mr Chermak [Member]
Common stock shares issued								1,000,000
Common Stock Class B [Member] | Mr Ansari [Member]
Common stock shares issued								1,000,000
Intellectual Property License Agreement [Member] | Common Stock Class A [Member]
Common stock shares issued	5,100,000	10,479,431	10,459,199
Royalty percentage of net sale	5%
Reticulate Micro, Inc. [Member]
Convertible promissory note		$ 45,000
Stock Issued		1,798,767
Accrued interest		$ 84,888
Convertible notes and accrued interest		$ 2,369,500
Common Stock Class B [Member]
Common Stock shares outstanding		2,000,000	2,000,000
Common Stock voting shares		100	100
Class A [Member]
Number of shares held		3,301,233	3,301,233
Voting Rights in Investee		1.57%	1.57%

INCOME TAXES (Details )

INCOME TAXES (Details ) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Pre-tax loss	$ 687,143	$ 1,059,128
U.S. statutory [Memner]
Pre-tax loss	$ (687,143)	$ (1,059,128)
U.S. federal corporate income tax rate	21%	21%
Expected U.S. income tax credit	$ (144,300)	$ (222,417)
Permanent differences	54,394	125,898
Change of valuation allowance	89,906	96,519
Effective tax expense	$ 0	$ 0

INCOME TAXES (Details 1)

INCOME TAXES (Details 1) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
INCOME TAXES
Net operating losses carried forward	$ 2,535,257	$ 2,445,350
Less: Valuation allowance	(2,535,257)	(2,445,350)
Net deferred tax assets	$ 0	$ 0

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	Dec. 31, 2024	Sep. 30, 2024
INCOME TAXES
Net operating loss carryforwards	$ 12,073,000	$ 11,645,000

DEFERRED REVENUE (Details Narra

DEFERRED REVENUE (Details Narrative) - USD ($)	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Sep. 30, 2024
DEFERRED REVENUE
Revenue from Contracts with Customers	$ 230,835	$ 0
Deferred revenues	195,524		$ 2,914
Revenues	$ 38,225	$ 2,411

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)		1 Months Ended
	May 07, 2024	Feb. 07, 2025	Jan. 31, 2025	Jan. 27, 2025
Common stock shares issued	3,000,000
Subsequent Event [Member]
Accrued interest			$ 4,500	$ 4,500
Convertible notes issued		$ 1,133,000
Proceeds from Convertible Notes		$ 195,740
Common stock shares issued			180,000	180,000
Debt Converted to Equity		884,955